SANUWAVE Health, Inc. Common Stock (SNWV) - Cash Flow Conversion Efficiency
Based on the latest financial reports, SANUWAVE Health, Inc. Common Stock (SNWV) has a cash flow conversion efficiency ratio of 0.216x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($397.00K) by net assets ($1.84 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is SANUWAVE Health, Inc. Common Stock's balance sheet to measure how much of total assets are equity-financed.
SANUWAVE Health, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how SANUWAVE Health, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check SNWV cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
SANUWAVE Health, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SANUWAVE Health, Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Yesil Gayrimenkul Yatirim Ortakligi AS
IS:YGYO
|
0.005x |
|
China Bicycle Co Holdings Ltd
SHE:200017
|
-0.043x |
|
Dsr Wire
KO:069730
|
0.055x |
|
Seoul Auction Co. Ltd
KQ:063170
|
0.048x |
|
Orient Ceratech Limited
NSE:ORIENTCER
|
0.100x |
|
Chilwa Minerals Ltd
AU:CHW
|
-0.071x |
|
BP Plastics Holding Bhd
KLSE:5100
|
0.020x |
|
Sajo Oyang
KO:006090
|
0.010x |
Annual Cash Flow Conversion Efficiency for SANUWAVE Health, Inc. Common Stock (2006–2025)
The table below shows the annual cash flow conversion efficiency of SANUWAVE Health, Inc. Common Stock from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see market value of SANUWAVE Health, Inc. Common Stock.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.62 Million | $3.88 Million | 2.394x | +1340.14% |
| 2024-12-31 | $-12.72 Million | $2.46 Million | -0.193x | -283.68% |
| 2023-12-31 | $-43.18 Million | $-4.54 Million | 0.105x | -74.90% |
| 2022-12-31 | $-41.01 Million | $-17.17 Million | 0.419x | +154.48% |
| 2021-12-31 | $-38.96 Million | $-6.41 Million | 0.165x | -82.25% |
| 2020-12-31 | $-13.72 Million | $-12.72 Million | 0.927x | +45.53% |
| 2019-12-31 | $-10.06 Million | $-6.41 Million | 0.637x | +170.14% |
| 2018-12-31 | $-15.36 Million | $-3.62 Million | 0.236x | +52.39% |
| 2017-12-31 | $-9.88 Million | $-1.53 Million | 0.155x | -66.57% |
| 2016-12-31 | $-6.91 Million | $-3.20 Million | 0.463x | -21.67% |
| 2015-12-31 | $-5.88 Million | $-3.47 Million | 0.591x | -86.27% |
| 2014-12-31 | $-1.55 Million | $-6.68 Million | 4.305x | +572.21% |
| 2013-12-31 | $-6.13 Million | $-3.92 Million | 0.640x | -2.69% |
| 2012-12-31 | $-6.52 Million | $-4.29 Million | 0.658x | -88.55% |
| 2011-12-31 | $-1.54 Million | $-8.83 Million | 5.748x | +930.25% |
| 2010-12-31 | $-10.52 Million | $-5.87 Million | 0.558x | -47.66% |
| 2009-12-31 | $-5.88 Million | $-6.27 Million | 1.066x | +85.53% |
| 2008-12-31 | $-72.97K | $-41.92K | 0.575x | +20.83% |
| 2007-12-31 | $-46.42K | $-22.07K | 0.475x | +25.28% |
| 2006-12-31 | $-10.73K | $-4.07K | 0.380x | -- |
About SANUWAVE Health, Inc. Common Stock
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses no… Read more